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Background: Autophagy (macroautophagy), a cellular process of “self-eating”, segregates damaged/aged
organelles into vesicles, fuses with lysosomes, and enables recycling of the digested materials. The precise origin
(s) of the autophagosome membrane is unclear and remains a critical but unanswered question. Endoplasmic
reticulum, mitochondria, Golgi complex, and the plasma membrane have been proposed as the source of
autophagosomal membranes.
Findings: Using electron microscopy, immunogold labeling techniques, confocal microscopy, and flow cytometry
we show that mitochondria can directly donate their membrane material to form autophagosomes. We expand
upon earlier studies to show that mitochondria donate their membranes to form autophagosomes during basal
and drug-induced autophagy. Moreover, electron microscopy and immunogold labeling studies show the first physical
evidence of mitochondria forming continuous structures with LC3-labeled autophagosomes. The mitochondria forming
these structures also stain positive for parkin, indicating that these mitochondrial-formed autophagosomes represent a
novel mechanism of parkin-associated mitophagy.
Conclusions: With the on-going debate regarding autophagosomal membrane origin, this report demonstrates that
mitochondria can donate membrane materials to form autophagosomes. These structures may also represent a novel
form of mitophagy where the mitochondria contribute to the formation of autophagosomes. This novel form of
parkin-associated mitophagy may be a more efficient bio-energetic process compared with de novo biosynthesis of a
new membrane, particularly if the membrane is obtained, at least partly, from the organelle being targeted for later
degradation in the mature autolysosome.
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Autophagy involves the segregation of subcellular material
into double membrane structures (autophagosomes) that
then fuse with lysosomes (autolysosomes) wherein the
cellular cargo is subsequently degraded by lysosomal hydro-
lases. This process facilitates the digestive degradation
of aged, damaged, or unneeded organelles including mito-
chondria, Golgi complex, and endoplasmic reticulum [1].* Correspondence: clarker@georgetown.edu
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unless otherwise stated.Understanding of the autophagic machinery has advanced;
however the primary source of the phospholipid bilayer
that creates the autophagosome membrane has remained
unclear [2,3].
The difficulty in identifying the origin of cellular material
donated to form autophagosome membranes reflects the
inability of specific markers for each subcellular organelle
to carry over to autophagosomes. Thus, various organelles
have been proposed to be autophagosome membrane
donors including the plasma membrane, endoplasmic
reticulum, Golgi complex, mitochondria, and even a de
novo generation model [2,3]. The endoplasmic reticulumtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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rent presence of rough endoplasmic reticulum integral
membrane proteins both in autophagosome membrane
preparations and electron microscopy images [4,5]. How-
ever, contradictory data emerged indicating only 30% of all
autophagosomes are associated with the endoplasmic
reticulum, suggesting the involvement of other organelles
in the formation of autophagosomes [6]. More recently,
the outer mitochondrial membrane was proposed to serve
as a donor source for starvation-induced autophagosome
formation [7]. Time-lapse photography data suggested
that the early autophagy protein ATG5 and the autop-
hagosomal marker LC3 translocate to puncta localized
on mitochondria, and that labeled outer mitochondrial
membrane protein concurrently marked both autopha-
gosomes and mitochondria in data obtained following
serum starvation of a rat kidney cell line [8,9]. However,
this study is limited because of the primary use of confocal
microscopy and the general observation that localization
is to be anticipated since the mitochondria are engulfed
within mature autophagosomes during mitophagy. The
resolution provided by electron microscopy (EM) is
needed to directly show autophagosome structures,
their content, and their special relationships with mito-
chondria; this evidence has been notably lacking. WeFigure 1 Drug-induced autophagy in ER + breast cancer cells exhibit ele
of the mitochondrial membrane in autophagosome membrane develop
cancer cells. B. LCC9 cells treated with 100 nM fulvestrant for 72 hours. C. LCC
with 10 μM Imatinib for 72 hours. M indicates mitochondria; Av indicates an ashow, for the first time, visual evidence of the contribu-
tion of mitochondrial membrane donation to autopha-
gosome formation in both basal and drug-induced
autophagy in a human breast cancer cell line. More-
over, these mitochondria donating membranes to form
autophagosomes stain positive for the mitophagy-related
protein parkin, suggesting a novel mechanism of mitophagy
whereby the mitochondria contribute to autophagosome
formation, other than being engulfed by the forming
autophagosome [10].
Materials and methods
The following materials were obtained as indicated:
Imatinib and ICI 182,780 (Tocris Bioscience, Ellisville,
MO); penicillin and Improved Minimal Essential Medium
(IMEM; Gibco Invitrogen BRL, Carlsbad, CA); bovine
calf charcoal stripped serum (CCS) (Equitech-Bio Inc,
Kerrville, TX); Lipofectamine RNAiMax reagent (Invitro-
gen); Estrogen receptor-α (ER) shRNA (Evrogen, Moscow,
Russia); GFP-LC3 (Addgene, Cambridge, MA); EndoTracker
Red, Golgi-RFP, MitoTracker-GFP, MitoTracker-RFP
(Invitrogen); Cyto-ID Autophagosome detection kit (Enzo
Life Sciences); LC3B and parkin antibody (Cell Signaling
Technology, Danvers, MA); PINK1 and parkin siRNA
(Origene, Rockville, MD).vated autophagosome formation and indicate a direct contribution
ment. Electron micrograph images of A. vehicle treated LCC9 breast
9 cells transfected with estrogen receptor-α shRNA. D. LCC9 cells treated
utophagic vesicle; * indicates mitochondria-autophagosome interaction.
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free IMEM media containing 5% CCS. Cells were grown
at 37°C in a humidified, 5% CO2:95% air atmosphere. Cells
were plated in 10 cm dishes and treated with 0.1% v/v
ethanol vehicle, 100 nM fulvestrant, or 10 μM Imatinib
for 72 hours, or transfected with four shRNA constructs
targeting ER-α. EM was performed as previously described
[11]. Briefly, cells were pelleted and fixed with 2.5% glutar-
aldehyde and postfixed with 0.5% osmium tetroxide. Cells
were then dehydrated and embedded in Spurs epoxy resin.
Embedded cells were cut into ultrathin sections (90 nm),
double-stained with uranyl acetate and lead citrate, and
viewed with a Philips CM10 transmission electron micro-
scope (Phillips Electronics). Autophagosome number and
size were quantified using ImageJ software.
LCC9 cells were transfected with GFP-LC3B and con-
trol or ERα shRNA, 0.1% v/v ethanol vehicle, 500 nM
ICI, or 10 μM Imatinib and with lentiviral RFP-labeled
organelle trackers (endoplasmic reticulum, golgi complex,
and mitochondria) for 24 hours. Cells were counterstained
with DAPI and confocal microscopy was performed using
an Olympus IX-70 confocal microscope (LCCC Imaging
Shared Resources) to determine LC3-positive punctate
formation and LC3 co-localization with different cellularFigure 2 Mitochondria directly donate membrane material to form au
breast cancer cells. B. LCC9 cells treated with 100 nM fulvestrant for 72 hours. C. L
with 10 μM Imatinib for 72 hours. M indicates mitochondria; Av indicates an aorganelles. LCC9 cells were treated with vehicle, serum
starvation, 500 nM ICI, 2 ng/mL tunicamycin, transfected
with ATG7 siRNA (negative control), transfected with
ERα shRNA, transfected with parkin siRNA, or treated
with 10 μM Imatinib for 48 hours. Cells were incubated
with MitoTracker-GFP for 24 hours prior to cell har-
vesting. Cells were collected and treated with a modified
monodansylcadaverine. Cells were sorted by flow cytome-
try to quantify autophagosome and mitochondria number
(LCCC Flow Cytometry Shared Resource).
The effect of mitophagy on antiestrogen responsiveness
was determined by crystal violet cell density assay. Briefly,
5 x 103 cells/mL LCC9 cell in IMEM containing 5% CCS
were transfected with control or PINK1 siRNA and were
plated in 24-well tissue culture plates. On day 1 after plat-
ing, cells were treated with varying doses of fulvestrant
(10 nM-1000 nM). On day 3, medium was aspirated
and cells were stained with crystal violet. Cells were per-
meabilized using citrate buffer and absorbance was read at
660 nm using a plate reader.
To confirm the effect of treatments on autophagy and
subcellular localization, western blot hybridization was
used to measure LC3-I/LC3-II, p62, PINK1, parkin, and
COXIV. Treated cell monolayers were solubilized in lysistophagosomes. Electron micrograph images of A. vehicle treated LCC9
CC9 cells transfected with estrogen receptor-α shRNA. D. LCC9 cells treated
utophagic vesicle; * indicates mitochondria-autophagosome interaction.
Figure 3 Autophagosome number, size quantification, and
percent mitochondria developing vesicles. Autophagosomes
were counted (A) and measured (B) using Image J software from
electron microscopy images of LCC9 breast cancer cells. n = 3-5,
*p < 0.05. C. Mitochondria were counted and graphed as percent of
mitochondria forming vesicles. n = 5-7.
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ninic acid assay, and proteins were size fractionated by
polyacrylamide gel electrophoresis and transferred to nitro-
cellulose membranes. Non-specific binding was blocked
by incubation with Tris-buffered saline containing 5%
powdered milk and 1% Triton X-100. Membranes were
incubated overnight at 4°C with primary antibodies, fol-
lowed by incubation with polyclonal horseradish perox-
idase (HRP)-conjugated secondary antibodies (1:2000)
for 1 hour at room temperature. Immunoreactive products
were visualized by chemiluminescence (SuperSignal Femto
West, Pierce Biotechnology, Rockford, IL) and quantified
by densitometry using the ImageJ digital densitometry
software (http://rsbweb.nih.gov/ij/). Protein loading was
visualized by incubation of stripped membranes with a
monoclonal antibody to β-actin or β-tubulin (1:1000).
All data are presented as the mean ± standard error of
the mean (SEM). Statistical differences were evaluated
by one way analysis of variance (ANOVA) followed by
Dunnett post hoc test. The criterion for statistical signifi-
cance was set at p < 0.05 prior to initiation of the study.
Results and discussion
Autophagy is often increased in response to stress, starva-
tion, and drug treatment [12]. Antiestrogens (tamoxifen
(TAM) and Fulvestrant (ICI)) induce autophagy in ERα
expressing human breast cancer cells [12-14]. This autoph-
agy induction is associated with cell survival, suggesting
that it is a major determinant of resistance to these drugs
[15,16]. Using the LCC9 (ER+, estrogen independent,
ICI resistant, TAM cross-resistant) [17] and MCF7 (ER+,
estrogen dependent, ICI and TAM sensitive) breast cancer
cell line, electron microscopy was used to investigate the
effect of ER knockdown and treatment with antiestrogens
and other autophagy-inducing drugs on autophagosome
formation. Figure 1A shows that LCC9 vehicle treated
(control) cells exhibit a high level of basal autophagy as
indicated by the presence of autophagosomes marked
Av (autophagic vacuole). Treatment with ICI increased
the formation of autophagosomes (Figure 1B), as did ER
knockdown that mimics the effects of ICI on ER expression
(Figure 1C). Imatinib mesylate (Gleevec®), a c-abl inhibitor
previously shown to induce autophagy in chronic myeloid
leukemia cells [18], was also used to stimulate further
autophagosome formation (Figure 1D). Higher magnifica-
tion EM images show that mitochondria directly contrib-
ute their membrane material to form autophagosomes
(Figure 2). In all electron microscopy images viewed in this
study, we found at least one example of mitochondrial
membranes forming contiguous structures with the mem-
branes of developing autophagosomes (as indicated by *).
Quantification of autophagosome number and size are
shown in Figure 3. All treatments significantly increased
autophagosome number, while antiestrogen therapy andER shRNA treatments increased autophagosome size.
The percentage of mitochondria forming these continuous
vesicle-like structures was also determined (Figure 3C).
To confirm induction of autophagy using these experi-
mental conditions, LCC9 cells were transfected with
GFP-LC3 and treated either with vehicle (control), 500
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Confocal microscopy showed that antiestrogen therapy,
knockdown of ERα, and Imatinib treatment each in-
duced LC3-positive puncta formation, demonstrating
that these conditions stimulate the initiation of autophagy
(Figure 4A). Furthermore, western blot hybridization
on protein lysates from LCC9 cells treated with vehicle
control, 100 nM ICI, transfected with ER shRNA, or 10 μM
Imatinib were used to confirm treatment effects on LC3
and p62 levels (Figure 4B). All treatments increased LC3-IIFigure 4 Vesicles forming from mitochondria are autophagosomes. A
vehicle, 500 nM ICI, ERα shRNA, or 10 μM Imatinib for 24 hours and count
LC3-positive puncta formation. B. LCC9 cells were treated with 0.1% ethan
protein isolated. Western blot hybridization was used to determine LC3-I/
500 nM ICI, serum starvation, 2 ng/mL tunicamycin, 10 μM Imatinib, or tra
24 hours. Autophagosome (modified monodansylcadaverine) and mitoch
D. LC3-immunogold EM of LCC9 cells. M indicates mitochondria; Av indic
interaction; arrows indicate LC3-immunogold particles. E. Mitochondria were c
LC3-immunogold or unlabeled. n = 3-4, *p < 0.05.formation in LCC9 cells, indicating that ICI, Imatinib,
and ER knockdown increased autophagosome formation.
ER knockdown and ICI treatment decreased p62 levels
showing that these drugs increased autophagic flux.
However treatment of LCC9 cells with Imatinib increased
p62, suggesting that the c-abl inhibitor blocked autophagic
flux by preventing lysosome degradation of autophago-
somes. The effect of imatinib on autophagy and anties-
trogen resistance will be further explored in future work.
LCC9 cells were treated either with vehicle (control), or. LCC9 cells were transfected with GFP-LC3, treated with 0.1% ethanol
erstained with DAPI. Confocal microscopy was used to determine
ol vehicle, 100 nM ICI, ERα shRNA, or 10 μM Imatinib for 72 hours and
LC3-II and p62 levels. C. LCC9 cells were treated with vehicle,
nsfected with ATG7 siRNA, PARK2 (parkin) siRNA, or ERα shRNA for
ondria (MitoTracker-GFP) fold change was determined by flow cytometry.
ates an autophagic vesicle; * indicates mitochondria-autophagosome
ounted and represented as percent of mitochondria either labeled with
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(as a positive control), ATG7 siRNA (as a negative control),
ERα shRNA, or 10 μM Imatinib for 24 hours to increase
autophagy. Prior to cell harvesting, cells were incubated
with lentiviral MitoTracker-GFP. Cells were collected
and treated with a modified monodansylcadaverine and
sorted by flow cytometry to quantify autophagosome and
mitochondria number (Figure 4C). Serum starvation, ICI,
tunicamycin, ERα shRNA, or Imatinib treatment resulted
in increased autophagosome formation. Serum starvation,
ICI, tunicamycin, and ERα shRNA decreased overall mito-
chondrial content when compared with vehicle treated
control. Imatinib had no significant effect on mitochon-
drial content; consistent with the maintenance of p62
levels indicating that autophagic flux is likely inhibited
by drug treatment.
Transfection of LCC9 cells with ATG7 siRNA to inhibit
autophagy reduced basal autophagosome formation with
no significant change in mitochondrial flux. InhibitionFigure 5 Co-localization of autophagosomes and cellular organelles.
incubated with either endoplasmic reticulum dye, Golgi complex-RFP, or M
Confocal microscopy was used to determine the co-localization of LC3 pun
autophagosome co-localizing with different cellular structures was determiof mitophagy, via parkin knockdown, also inhibited mito-
chondrial flux with no effect on autophagosome forma-
tion. These data indicate a reciprocal relationship between
autophagy and mitochondria, suggesting either that mito-
chondria are the cellular content of autophagosomes
(mitophagy) and/or that mitochondria are being used
as the “raw material” to form autophagosomes as we
observe in Figure 2. Furthermore, co-localization of GFP-
LC3 with Mitotracker-RFP, GolgiTracker-RFP, or Endo-
Tracker (endoplasmic reticulum dye) was determined by
confocal microscopy (Figure 5). We show that LC3 pre-
dominately localizes with the mitochondria. Moreover,
images from LCC9 cells incubated with LC3-immunogold
and studied by electron microscopy show that LC3 is lo-
calized to vesicles forming from mitochondria (Figure 4D),
supporting the interpretation that the vesicles developing
from mitochondria are autophagosomes. Quantification
of the LC3-immunogold EM staining shows that the per-
centage of mitochondria per section that stain positive forA. LCC9 cells were transfected with GFP-LC3 for 24 hours. Cells were
itoTracker-RFP and treated with 500 nM ICI to induce autophagy.
cta with different cellular organelles. B. The percent of LC3-positive
ned. n = 5-6.
Cook et al. Cell & Bioscience 2014, 4:16 Page 7 of 9
http://www.cellandbioscience.com/content/4/1/16LC3 is approximately 35% (Figure 4E). The percentage
of mitochondria forming vesicles (Figure 3C) and the
percentage of mitochondria stained positive for LC3
(Figure 4E) are similar, further supporting the likelihood
that vesicles forming from mitochondria are autophago-
somes. Data obtained by confocal microscopy confirm that
these treatments induce autophagy, the flow cytometry
data reflects both autophagosome and mitochondria flux,
and the EM images show that mitochondrial membranes
contribute to the formation of a membrane encapsulated
autophagosomal-like vesicle, most likely reflecting the re-
cycling of damaged or unnecessary mitochondria to form
autophagosomes.Figure 6 Autophagosomes forming from mitochondria is a novel form
PINK1 in mitochondrial and cytoplasmic fractions of control and fulvestrant
B. Effect of mitophagy inhibition by PINK1 knockdown on antiestrogen sen
and mitochondria in LCC9 cells treated with 100 nM ICI for 72 hours. D. Qu
cells. n = 5. E. EM image of parkin-immunogold stained LCC9 cells. Mitochond
Av indicates an autophagic vesicle; * indicates mitochondria-autophagosomeLastly, we investigated whether the mitochondria-
forming autophagosomes may be a form of mitophagy.
LCC9 cells were treated with vehicle control or 100 nM
ICI for 72 hours. Mitochondrial or cytoplasmic protein
fractions were collected and western blot hybridization
performed to determine PINK1, parkin, COX-IV (mito-
chondrial control), or β-tubulin (cytoplasmic control).
Treatment with ICI increased both PINK1 and parkin
localization to the mitochondria (Figure 6A). Moreover,
inhibition of mitophagy through PINK1 knockdown resen-
sitized LCC9 cells to antiestrogen therapy, suggesting a
dependence of LCC9 cells on functional mitophagy to
maintain an antiestrogen resistant phenotype (Figure 6B).of parkin-associated mitophagy. A. Distribution of parkin and
treated LCC9 cells as determined by western blot hybridization.
sitivity in LCC9 cells. C. Confocal microscopy of PINK1, parkin, LC3,
antification of parkin-immunogold EM parkin distribution within LCC9
ria forming vesicles stain positive for parkin. M indicates mitochondria;
interaction; arrows indicate parkin-immunogold particles.
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cells exhibit an elevated level of endogenous parkin ex-
pression when compared with their endocrine sensitive
parental cell line (data not shown), further supporting an
important role of mitophagy in antiestrogen responsive-
ness. Additional studies into the mechanistic contribution
of mitophagy to antiestrogen resistance are ongoing.
Confocal microscopy was performed on LCC9 cells
treated with 100 nM ICI and either transfected with
GFP-LC3 or incubated with a PINK1 antibody, parkin
antibody, or mitotracker-RFP. As shown in Figure 6C when
mitophagy is stimulated by ICI treatment, mitochondria
localize with LC3, PINK1, and parkin. Moreover, LC3 also
co-localizes with parkin, suggesting that mitochondria
labeled with parkin are then either used to form auto-
phagosomes or are engulfed by the forming autophago-
somes. EM images suggest that both processes occur in
ICI treated LCC9 cells; Figure 2 shows autophagosomes
forming from mitochondria membranes, while Figure 7B
shows an example of classical mitophagy where a mito-
chondria is localized inside a formed autophagosome.
LCC9 cells were incubated with parkin-immunogold, and
subsequent electron microscopy showed that parkin local-
ized to mitochondria forming autophagosomes (Figure 6D).
Thus, autophagosomes developing from mitochondria
appear to represent a novel mechanism of mitophagy.
Cellular parkin distribution is shown in Figure 6E, with
parkin predominately localized within the cytoplasm and
at mitochondria forming autophagosomes.Figure 7 Mitophagy in human breast cancer cells. A. EM image of MCF
the mitochondria and inhibits glucose-regulated protein 75. Image indicate
lines. B. EM image of LCC9 cells treated with ICI. Image shows an example
an autophagosome.Autophagy is thought to occur naturally in most cells,
and breast cancer cells often exhibit increased autophagy
when compared with immortalized normal breast epithe-
lial cells. Antiestrogen resistant breast cancer cells exhibit
a further increase in autophagy when compared with
their therapy sensitive counterparts [15,19,20]. We cannot
exclude the possibility that these higher levels of autoph-
agy in cancer cells result in the use of cellular materials or
processes not commonly used in normal cells. Nonethe-
less, the use of preexisting target organelle membranes
is an energy efficient process compared with de novo
biosynthesis of a new double membrane, particularly if
the membrane is at least partly obtained from the organ-
elle being targeted for later degradation in the mature
autolysosome. Moreover, we show that the process of
mitochondrial-mediated autophagosome formation also
occurs in MCF7 cells (ER+, antiestrogen sensitive breast
cancer cells), implying that this phenomenon occurs more
broadly than in just the LCC9 variant (Figure 7A). Since
autophagy clearly plays an important role in breast cancer
progression and therapeutic responsiveness [12,21,22],
understanding how autophagy occurs may improve our
ability to efficiently target this prosurvival pathway.
In conclusion, we show the first physical evidence, by
electron microscopy, that mitochondria can supply mem-
brane material during the creation of autophagosomes.
We demonstrate that this occurs not only during serum
starvation [8], but also during both basal (in the presence
of serum and vehicle) and drug-induced autophagy. We7 cells treated with MKT-077, a cationic drug that concentrates in
s that mitochondria forming autophagosomes occur in other cell
of classical mitophagy where a mitochondria is engulfed by
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oping from mitochondria may represent a novel mechan-
ism of parkin-associated mitophagy, where mitochondrial
membrane material can be contributed to formation of
the developing autophagosome, rather than the auto-
phagosome forming around parkin-labeled mitochondria.
While we did not find similar early structures for autopha-
gosomes incorporating other subcellular organelles, the
data imply that the autophagic removal of Golgi/secretory
vacuoles (crinophagy), endoplasmic reticulum (reticulo-
phagy), and other organelles may also proceed with the
contribution of target organelle membrane to formation
of the membranes of the subsequent autophagosomes.
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